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Editorial on the Research Topic
Interplay of Infection and Microbiome
The composition and function of the animal body is now widely acknowledged to be critically
linked with the numerous microscopic organisms that have a habitat within the animal host. There
are numerous lines of evidence that these tiny ecosystems can be critical for the local function of
each tissue site, or can act as a pathogen defense system, or in some cases can be associated with
disease. There is gathering evidence that the hosts diet, genotype, and lifestyle can impact on these
microbial ecosystems throughout the body. The composition of the microbiota, or microbiome of
the host, from humans to a myriad of animal hosts, has been the focus of recent research.
More and more it is becoming apparent that interactions between pathogenic infections and the
local microbial community at the infection site is an important factor in the outcomes of diseases
across humans and various animals.
The topics in this Research Topic issue span across the human and animal sphere and explore
the infection and microbiota interplay through three major themes. The first theme focusses on
the interactions between microbiome, metabolites and host responses; the second theme addresses
microbiome compositions as predictive indicators or associated factors in cancers; and the final
theme addresses the functional molecular and genomic knowledge that is now emerging on key
microbiome players.
IS IT THE MICROBIOME COMPOSITION OR THE RESULTING
METABOLOME THAT IS MOST INFLUENTIAL?
A priority to microbiome researchers and those considering probiotic prophylaxis is the concept of
a pre-disposing immune environment due to the status of the local microbiome and how that may
then interplay into the infection.
The role of L-tryptophan as a keystonemetabolite that is critical for host nutritional and immune
regulation, but also as a target for the gut microbiomemanipulation to orchestrate the host immune
status is comprehensively reviewed (Gao et al.). The review explores the molecular processes and
metabolic compounds involved, identifies the knowns and unknowns for the major metabolites in
the host and microbial pathways, outlines lifestyle and environmental factors that may influence
these pathways, and outlines the diseases where this host and microbiome interplay around a
keystone metabolite may be important.
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In the article by Delgado-Diaz et al. the influence of
metabolic constituents associated with optimal and non-
optimal vaginal microbiome compositions on cervicovaginal
epithelial cellular responses was explored. The authors
examined the inflammatory response profile of epithelial
cells exposed to the metabolic profile associated with a
bacterial vaginosis microbiome (non-optimal) compared to
that of a lactobacilli dominated (optimal) vaginal microbiome.
They found that short chain fatty acids, at levels observed
in women with bacterial vaginosis, were associated with
dysregulation of the immune response to inflammatory stimuli
that may explain, in part, the pro-inflammatory cytokine
and chemokine profile observed in women experiencing
bacterial vaginosis.
Further to this insight into the disease burden of bacterial
vaginosis, an approach to define a standardized (“universal”)
donor screening for a vaginal microbiome transplant has
been outlined in the issue by DeLong et al.. Microbiome
transplants, whilst limited success has been reported to date,
are viewed as a likely more successful methodology to
create a longer term change in a microbial ecosystem than
administration of a probiotic, and particular in the case of this
polymicrobial condition.
Finally, in this theme, the current knowledge of how the
host gut microbiota interplays into the immune responses to
nematodes and protozoa in mice and mosquito vectors is
reviewed (Yordanova et al.), presenting a fascinating summary of
the structural and physiological environments the parasites have
to adapt in distinct life-cycle phases.
COULD THE MICROBIOME BE AN
INDICATOR OR PREDICTIVE BIOMARKER
FOR CANCER?
The role of microbiome signatures as a potential indicator of
oral and oropharyngeal cancers was explored in a case-control
study of 83 participants conducted by Lim et al.. In this study,
which requires further validation, the findings indicated that
profiling the oral rinse microbiome had 100% sensitivity and 90%
specificity to predict these cancers.
Differences in the bacterial diversity profiles and also higher
representations of certain bacterial genera were identified when
microbial profiles of mid-stream urine samples of males with
bladder cancer was compared to controls. This study (Wu et al.)
of 60 men in total has provided preliminary evidence that there
may be a microbiome profile consistent with the presence of
bladder cancer.
A study presented in the issue comparing the profile of
the mucosal microbiome from the gastrointestinal surfaces
of patients with gastric antrum or duodenal ulcers identified
that there was a higher proportion of Helicobacter in those
with the gastric ulcers (Chen et al.). There were also a
number of species that were over-represented in the specimens
from the duodenal ulcers than the gastric sites, information
which may have relevance in future management of this
condition as the composition of the local microbiome could
interplay into the pathology (in addition to the causation
by Helicobacter).
INSIGHTS INTO KEY MICROBIOME
PLAYERS
Intestinal helminth infections have been associated with
alterations in the gut microbiome; however, whether this
directly relates to helminths or is an indirect consequence of
the immunological and metabolic response to the infection
has not been certain. Given helminths have to compete
with the gut microbiome to establish the infection, Midha
et al.. have examined the antibacterial properties of the
intestinal roundworm Ascaris suum, and identified excretory
and secretory factors with broad spectrum antimicrobial factors.
These findings demonstrate a specific functional impact on
the microbiome as part of the pathogenic process for at least
this helminth.
Campylobacter concisus, an organism known to colonize the
oral cavity of humans, but has been identified as over-represented
or dominant in a number of conditions (gastroenteritis, Barrett’s
Esophagus, and gingivitis or periodontal diseases), although
as this comprehensive review points out many of the studies
were underpowered or did not include appropriate controls
meaning association with these conditions cannot yet be
concluded. However, of particular interest is irritable bowel
disease, where over-representation of C. concisus in the oral
cavity has been reported in more than one study. The review
also presents genomic analysis of the species, pathogenic
mechanism, pathology and inflammatory associations, and
anti-microbial resistance properties. The review (Liu et al.)
also shares insights into other potentially important members
of the genus.
The capacity of Lactobacilli strains (and their secretions)
isolated from fecal samples from healthy children to prevent
or disperse biofilms formed by Vibrio cholera and Vibrio
paraheamolyticus was analyzed Kaur et al. to investigate their
preventative or therapeutic potential against this diarrheal
disease. The authors found that the low pH elicited by the
strains was the main mechanism of antimicrobial activity against
the Vibrio. However, in a strain specific manner, some culture
supernatants where able to inhibit biofilm formation or disperse
biofilms, even when the pH was neutralized.
CONCLUSIONS
The evidence is strong that the microbiome, metabolic profiles,
and interplay with the host are determining factors in infection
risk or potentially pathology associated with infection. However,
the precision medicine applications that could emerge, and
the therapeutic interventions remain in the distant future
until greater understanding of the physiological and molecular
features at play can be more rigorously and thoroughly profiled.
This issue presents some up to date and promising data and
reviews on this topic that point to the microbiome being a critical
focus for on-going research into infection.
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